vimarsana.com
Home
Live Updates
Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma Cancer Treatment : vimarsana.com
Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma Cancer Treatment : vimarsana.com
Tilray Medical Supports New Clinical Trial to Study Medical Cannabis in Glioblastoma Cancer Treatment
CANTANHEDE, Portugal, Oct. 16, 2023 -- Tilray Medical, a division of Tilray Brands, Inc. and a global leader in medical cannabis, empowering the therapeutic alliance between patients and...
Related Keywords
New Zealand ,
Spain ,
Canada ,
United States ,
Germany ,
Portugal ,
Netherlands ,
Australia ,
Cantanhede ,
Coimbra ,
Spanish ,
Canadian ,
America ,
Juan Manuel Sep ,
Raphael Gross ,
Luc Krol ,
Berrin Noorata ,
Juan Sepulveda ,
Denise Faltischek ,
Manuel Guzm ,
Guillermo Velasco ,
Bike Tour Foundation ,
Spanish Research Group Of Neuro ,
University Hospital ,
Cannabinoid Signalling Group ,
Cannabis Bike Tour Foundation ,
Company Nasdaq ,
Complutense Madrid University ,
Nasdaq ,
Head Of International Business ,
Complutense University Of Madrid ,
Tilray Brands Inc ,
Securities Exchange ,
Tilray Brands ,
Spanish Research Group ,
Complutense University ,
Tilray Medical ,
Medical Cannabis Bike Tour Foundation ,
Chief Strategy Officer ,
International Business ,
Medical Cannabis Bike Tour ,
Paradise Seeds ,
Medical Bike Tour Foundation ,
Latin America ,
Broken Coast ,
Tilray Medical Europe ,
Tilray Medical Canada ,
Tilray Medical Australia New ,
Statement Concerning Forward Looking Statements ,
Securities Act ,
Securities Exchange Act ,
Annual Report ,
Markets ,